Actively Recruiting
Characterisation of Endothelial Cells in Different Inflammatory Pathologies
Led by Royal Surrey County Hospital NHS Foundation Trust · Updated on 2024-09-25
105
Participants Needed
1
Research Sites
16 weeks
Total Duration
On this page
Sponsors
R
Royal Surrey County Hospital NHS Foundation Trust
Lead Sponsor
U
University of Surrey
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to understand how gene expression changes in endothelial cells during inflammatory conditions such as sepsis or after major abdominal surgery. The study focuses on identifying molecular pathways that differ during these inflammatory states to better understand how the immune system interacts with blood vessel cells and contributes to severe symptoms like low blood pressure and organ failure. Participants include healthy volunteers, surgical patients undergoing major surgery, and critically ill sepsis patients admitted to intensive care. Endothelial cells are collected using a safe technique involving a metal guidewire inserted into a vein in the arm. Samples are taken at specific times: once from healthy volunteers, once at peak inflammation from surgical and sepsis patients, and multiple times over 48 hours in some patients to observe changes over time. Participants will undergo endothelial cell biopsies and provide blood samples during their hospital stay. Researchers will analyze RNA from these cells to track gene expression changes at different time points. The primary outcome is the measurement of differential gene expression in endothelial cells over two years. This study also includes healthy control samples and gathers data to potentially improve understanding of inflammatory responses and treatment reactions.
CONDITIONS
Brief Title
Characterisation of Endothelial Cells in Different Inflammatory Pathologies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy volunteer
- Adult 18 years or older
- Able and willing to give consent
- Patients admitted to Royal Surrey County Hospital NHS Foundation Trust (RSFT) for planned major surgery
- Emergency admission to ICU at RSFT
- Meets the sepsis 3.0 definition
You will not qualify if you...
- Not currently a patient within the hospital
- Presence of inflammatory diseases such as arthritis, peripheral artery disease, vasculitis, diabetes, cardiovascular disease, and chronic kidney disease
- Currently on immunomodulatory medications like corticosteroids
- History of major trauma requiring hospitalization within the last 2 months
- Patients with restricted liberty, prisoners, or under legal protection
- Anticipated difficult venous cannulation
- Receiving vasopressor support prior to surgery
- Received chemotherapy within 2 weeks of sampling
- Immunocompromised status
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - One-time or up to 48 hours depending on participant group
Participants have endothelial cell samples collected from a vein in the arm using a metal guidewire to study inflammation in different conditions.
1 to 3 visits depending on group assignment
Duration - Up to 2 years
Researchers analyze gene expression changes in collected endothelial cells over up to 2 years to understand inflammation pathways.
Trial Site Locations
Total: 1 location
1
Royal Surrey NHS Foundation Trust
Guildford, Surrey, United Kingdom, GU27XX
Actively Recruiting
Research Team
B
Ben Creagh-Brown, BM, PhD
C
Charlie Piercy, MSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here